Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

94 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Deep sequencing reveals microRNAs predictive of antiangiogenic drug response.
García-Donas J, Beuselinck B, Inglada-Pérez L, Graña O, Schöffski P, Wozniak A, Bechter O, Apellániz-Ruiz M, Leandro-García LJ, Esteban E, Castellano DE, González Del Alba A, Climent MA, Hernando S, Arranz JA, Morente M, Pisano DG, Robledo M, Rodriguez-Antona C. García-Donas J, et al. Among authors: bechter o. JCI Insight. 2016 Jul 7;1(10):e86051. doi: 10.1172/jci.insight.86051. JCI Insight. 2016. PMID: 27699216 Free PMC article.
Incidence of osteonecrosis of the jaw in patients with bone metastases treated sequentially with bisphosphonates and denosumab.
Loyson T, Van Cann T, Schöffski P, Clement PM, Bechter O, Spriet I, Coropciuc R, Politis C, Vandeweyer RO, Schoenaers J, Dumez H, Berteloot P, Neven P, Nackaerts K, Woei-A-Jin FJSH, Punie K, Wildiers H, Beuselinck B. Loyson T, et al. Among authors: bechter o. Acta Clin Belg. 2018 Apr;73(2):100-109. doi: 10.1080/17843286.2017.1348001. Epub 2017 Jul 10. Acta Clin Belg. 2018. PMID: 28693379
Incidence of medication-related osteonecrosis of the jaw in patients treated with both bone resorption inhibitors and vascular endothelial growth factor receptor tyrosine kinase inhibitors.
van Cann T, Loyson T, Verbiest A, Clement PM, Bechter O, Willems L, Spriet I, Coropciuc R, Politis C, Vandeweyer RO, Schoenaers J, Debruyne PR, Dumez H, Berteloot P, Neven P, Nackaerts K, Woei-A-Jin FJSH, Punie K, Wildiers H, Beuselinck B. van Cann T, et al. Among authors: bechter o. Support Care Cancer. 2018 Mar;26(3):869-878. doi: 10.1007/s00520-017-3903-5. Epub 2017 Sep 30. Support Care Cancer. 2018. PMID: 28963584
Prospective evaluation of hypogonadism in male metastatic renal cell carcinoma patients treated with targeted therapies.
Bastin J, Werbrouck E, Verbiest A, Punie K, Bechter O, Woei-A-Jin FJ, Wolter P, Wildiers H, Lerut E, Dumez H, Decallonne B, Clement P, Vanderschueren D, Albersen M, Oyen R, Schöffski P, Beuselinck B. Bastin J, et al. Among authors: bechter o. Acta Clin Belg. 2019 Jun;74(3):169-179. doi: 10.1080/17843286.2018.1476115. Epub 2018 May 18. Acta Clin Belg. 2019. PMID: 29774795
ABCG2 Polymorphism rs2231142 and hypothyroidism in metastatic renal cell carcinoma patients treated with sunitinib.
Werbrouck E, Bastin J, Lambrechts D, Verbiest A, Van Brussel T, Lerut E, Machiels JP, Verschaeve V, Richard V, Debruyne PR, Decallonne B, Schöffski P, Bechter O, Wolter P, Beuselinck B. Werbrouck E, et al. Among authors: bechter o. Acta Clin Belg. 2019 Jun;74(3):180-188. doi: 10.1080/17843286.2018.1477229. Epub 2018 May 23. Acta Clin Belg. 2019. PMID: 29792121
Clinical Presentation, Natural History, and Therapeutic Approach in Patients with Solitary Fibrous Tumor: A Retrospective Analysis.
Schöffski P, Timmermans I, Hompes D, Stas M, Sinnaeve F, De Leyn P, Coosemans W, Van Raemdonck D, Hauben E, Sciot R, Clement P, Bechter O, Beuselinck B, Woei-A-Jin FJSH, Dumez H, Nafteux P, Wessels T. Schöffski P, et al. Among authors: bechter o. Sarcoma. 2020 Mar 26;2020:1385978. doi: 10.1155/2020/1385978. eCollection 2020. Sarcoma. 2020. PMID: 32300277 Free PMC article.
Impact of concomitant acid suppressive therapy on pazopanib efficacy and dose reductions in patients with metastatic renal cell carcinoma.
Van De Sijpe G, Beuselinck B, Van Nieuwenhuyse T, Poncelet R, Bechter O, Albersen M, Roussel E, Baldewijns M, Tack J, Spriet I. Van De Sijpe G, et al. Among authors: bechter o. Eur J Clin Pharmacol. 2020 Sep;76(9):1273-1280. doi: 10.1007/s00228-020-02902-3. Epub 2020 May 30. Eur J Clin Pharmacol. 2020. PMID: 32474662
Corrigendum to "Clinical Presentation, Natural History, and Therapeutic Approach in Patients with Solitary Fibrous Tumor: A Retrospective Analysis".
Schöffski P, Timmermans I, Hompes D, Stas M, Boecxstaens V, Sinnaeve F, De Leyn P, Coosemans W, Van Raemdonck D, Hauben E, Sciot R, Clement P, Bechter O, Beuselinck B, Woei-A-Jin FJSH, Dumez H, Nafteux P, Wessels T. Schöffski P, et al. Among authors: bechter o. Sarcoma. 2021 Jan 29;2021:4653987. doi: 10.1155/2021/4653987. eCollection 2021. Sarcoma. 2021. PMID: 33628084 Free PMC article.
94 results